TGF-β′s tumour suppressing effects are abrogated by interaction with inflammatory pathways including platelet derived growth factor (PDGF), and EGF autocrine loops, which enable immune evasion and metastatic spread [75]. Here, TGFB1 is linked to neoplasm.